5. References

  1. Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2022. Available at:  http://clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed September 8, 2022.
  2. IMB Micromedex® DRUGDEX® (electronic version). Truven Health Analytics, Greenwood Village, Colorado, USA. Available at: http://www.micromedexsolutions.com.libproxy.uthscsa.edu. Accessed September 8, 2022.
  3. Hesketh PJ, Kris MG, Basch E, et al. Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2017 Oct 1;35(28):3240-3261. 
  4. Hesketh PJ, Kris MG, Basch E, et al. Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. Published online July 13, 2020.
  5. Netupitant/palonosetron capsules (Akynzeo®) package insert. Helsinn Therapeutics (U.S.), Inc., June 2021. 
  6. Dolasetron mesylate tablets (Anzemet®) package insert. Validus Pharmaceuticals LLC, September 2021.
  7. Granisetron hydrochloride tablets package insert. Breckenridge Pharmaceutical, Inc., May 2022.
  8. Granisetron transdermal system (Sancuso®) package insert. Kyowa Kirin, Inc., December 2021.
  9. Ondansetron hydrochloride tablets/orally disintegrating tablets/oral solution (Zofran®, Zofran ODT®) Package Insert. Novartis Pharmaceuticals Corporation, October 2021.